Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 1
1953 1
1966 1
1968 6
1969 5
1970 3
1971 10
1972 6
1973 6
1974 7
1975 6
1976 4
1977 3
1981 2
1982 6
1983 4
1984 6
1985 5
1986 3
1987 2
1988 7
1989 3
1990 5
1991 5
1992 4
1993 7
1994 7
1995 5
1996 8
1997 6
1998 4
1999 7
2000 11
2001 3
2002 4
2003 13
2004 9
2005 8
2006 7
2007 8
2008 1
2009 4
2010 4
2011 3
2012 2
2013 2
2014 4
2015 3
2016 4
2017 4
2019 1
2020 2
2021 2
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations.
Wolf NI, Vanderver A, van Spaendonk RM, Schiffmann R, Brais B, Bugiani M, Sistermans E, Catsman-Berrevoets C, Kros JM, Pinto PS, Pohl D, Tirupathi S, Strømme P, de Grauw T, Fribourg S, Demos M, Pizzino A, Naidu S, Guerrero K, van der Knaap MS, Bernard G; 4H Research Group. Wolf NI, et al. Neurology. 2014 Nov 18;83(21):1898-905. doi: 10.1212/WNL.0000000000001002. Epub 2014 Oct 22. Neurology. 2014. PMID: 25339210 Free PMC article.
Molecular basis of Canavan disease.
Matalon R, Michals-Matalon K. Matalon R, et al. Eur J Paediatr Neurol. 1998;2(2):69-76. doi: 10.1016/s1090-3798(98)80044-5. Eur J Paediatr Neurol. 1998. PMID: 10724099 Review. No abstract available.
Recent advances in Canavan disease.
Matalon R, Michals-Matalon K. Matalon R, et al. Adv Pediatr. 1999;46:493-506. Adv Pediatr. 1999. PMID: 10645473 Review.
Trends in enzyme therapy for phenylketonuria.
Kim W, Erlandsen H, Surendran S, Stevens RC, Gamez A, Michols-Matalon K, Tyring SK, Matalon R. Kim W, et al. Among authors: matalon r. Mol Ther. 2004 Aug;10(2):220-4. doi: 10.1016/j.ymthe.2004.05.001. Mol Ther. 2004. PMID: 15294168 Free article. Review.
Lipomucopolysaccharidosis?
Matalon R, Dorfman A. Matalon R, et al. Lancet. 1968 Jun 15;1(7555):1314. doi: 10.1016/s0140-6736(68)92331-3. Lancet. 1968. PMID: 4172170 No abstract available.
Current status of biopterin screening.
Matalon R. Matalon R. J Pediatr. 1984 Apr;104(4):579-81. doi: 10.1016/s0022-3476(84)80551-x. J Pediatr. 1984. PMID: 6707819 No abstract available.
Physiological role of N-acetylaspartate: contribution to myelinogenesis.
Ledeen RW, Wang J, Wu G, Lu ZH, Chakraborty G, Meyenhofer M, Tyring SK, Matalon R. Ledeen RW, et al. Among authors: matalon r. Adv Exp Med Biol. 2006;576:131-43; discussion 361-3. doi: 10.1007/0-387-30172-0_9. Adv Exp Med Biol. 2006. PMID: 16802709 Review. No abstract available.
252 results